MedPath

Postprandial Effects of Functional Bread

Not Applicable
Completed
Conditions
Postprandial Hyperglycemia
Interventions
Dietary Supplement: Functional bread
Registration Number
NCT04289545
Lead Sponsor
University of Bergen
Brief Summary

This study investigates whether bread with added galactomannan, a soluble fiber, can reduce the postprandial glucose response in healthy overweight adults.

Detailed Description

This single-blind crossover-designed study wants to investigate the postprandial effect of functional bread in healthy overweight adults. Therefore, four types of bread, consumed by the participants, have added galactomannan in different amounts and viscosities, and one bread is the control bread.

The participants arrive after an overnight fast and before the consumption of bread, a fasting blood sample is taken.

After the ingestion, blood samples are taken at specific times. The area under the curve of the postprandial glucose is expected to differ between the functional breads.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • healthy, overweight adults (BMI between 25 and 30 kg/m2)
Exclusion Criteria
  • Known diagnosis of diabetes mellitus type 2
  • HbA1c at screening ≥ 48 mmol/mol
  • Other chronic diseases (heart disease, cancer) within the last 3 years
  • Pregnancy and lactation
  • Known drug or alcohol abuse
  • Unwilling to follow the study requirements

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Control BreadFunctional breadno added guar gum
Functional Bread 1Functional bread10% guar gum, low molecular weight
Functional Bread 3Functional bread15% guar gum, low molecular weight
Functional Bread 4Functional bread15% guar gum, high molecular weight
functional Bread 2Functional bread10% guar gum, high molecular weight
Primary Outcome Measures
NameTimeMethod
area under the curve of postprandial glucose180 minutes
Secondary Outcome Measures
NameTimeMethod
area under the curve postprandial insulin180 minutes

Trial Locations

Locations (1)

University of Bergen, Research Unit for Health Surveys

🇳🇴

Bergen, Norway

© Copyright 2025. All Rights Reserved by MedPath